A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer
Clinical trial NCT01586611 · UNKNOWN
Trial details
- NCT number
- NCT01586611
- Sponsor
- AHS Cancer Control Alberta
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2015-04-01
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.